Remus Pharmaceuticals Ltd.
REMUS
Remus Pharmaceuticals Ltd. Share Price
799.95 -27.55 (-3.33%)Fundamentals
Market Cap₹943Cr | EPS₹39.19 |
P/E Ratio (TTM)22.39 | Industry P/E (TTM)40.84 |
P/B Ratio3.68 | Long Term D/E0.07 |
ROE12.19% | Dividend Yield (TTM)0.10% |
Analysis
Overview
Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.
Strong Outperformer
Good Quality
Slight Price Fluctuation
Shareholding Pattern
Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.
FAQs on Remus Pharmaceuticals Ltd.
What is the share price of Remus Pharmaceuticals Ltd.?
The share price of Remus Pharmaceuticals Ltd. is ₹799.95 on NSE as of 21/6/2026, 9:28:09 am. Share prices may change frequently due to market movements.
What is the market capitalisation of Remus Pharmaceuticals Ltd.?
The market capitalisation of Remus Pharmaceuticals Ltd. is ₹943Cr as of 21/6/2026, 9:28:09 am
What is the current P/E ratio of Remus Pharmaceuticals Ltd.?
The current Price to Earnings (P/E) ratio of Remus Pharmaceuticals Ltd. is 22.40 as of 21/6/2026, 9:28:09 am
What is the current P/B ratio of Remus Pharmaceuticals Ltd.?
The Price to Book (P/B) ratio of Remus Pharmaceuticals Ltd. stands at 3.68 as of 21/6/2026, 9:28:09 am
What is the ROE of Remus Pharmaceuticals Ltd.?
Remus Pharmaceuticals Ltd. reported an ROE of 12.19% for the last reported financial year on a consolidated account basis.
What is the shareholding pattern of Remus Pharmaceuticals Ltd.?
As of 21/6/2026, 9:28:09 am, Remus Pharmaceuticals Ltd.’s shareholding pattern is: promoters hold 71.00%, FIIs hold 5.30%, DIIs hold 0.80%, and public shareholders hold 22.90%.
What is the 52-week high and low of Remus Pharmaceuticals Ltd.?
The 52-week high of Remus Pharmaceuticals Ltd. is ₹819.90 and the 52-week low is ₹793.00 as of 21/6/2026, 9:28:09 am.
What is the stock symbol of Remus Pharmaceuticals Ltd.?
The stock symbol of Remus Pharmaceuticals Ltd. is REMUS.
How to buy Remus Pharmaceuticals Ltd.?
You can buy Remus Pharmaceuticals Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.
What is the fair value of Remus Pharmaceuticals Ltd.?
The fair value of Remus Pharmaceuticals Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.
Income Statement
Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.
| Particulars (in Cr) | Mar 2026 | Y/Y Change |
|---|---|---|
| Operating Revenue | 853.63 | +37.60% |
| Other Income | 6.70 | +34.54% |
| Total Income | 860.33 | +37.58% |
| Total Expenditure | 801.17 | +38.61% |
| EBIDT | 63.39 | +25.10% |
| Depreciation | 2.76 | +47.59% |
| Interest | 1.47 | +0.68% |
| Tax | 12.99 | +45.63% |
| Net Profit | 36.99 | +27.24% |
Balance Sheet
A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Total Current Assets | 294.64 |
| Total Non-Current Assets | 284.01 |
| Fixed assets | 18.04 |
| Total Assets | 578.65 |
| Total Current liabilities | 149.10 |
| Total Non Current Liabilities | 41.82 |
| Total Equity Plus Liabilities | 578.65 |
| Total Shareholder Funds | 350.99 |
| Total Debt to Equity | 7.00% |
Cash Flow
Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.
| Particulars (in Cr) | Mar 2026 |
|---|---|
| Cash from Operating Activity | 18.18 |
| Cash from Financing Activities | 1.45 |
| Cash from Investing Activities | -15.03 |
| Net Cash Flow | 4.60 |
Time Period: Daily
SMA/EMA (Moving Average) Analysis
Bullish Moving Averages16
Bearish Moving Averages0
5 Day
787.6010 Day
739.7020 Day
731.4030 Day
755.2050 Day
718.40100 Day
686.10150 Day
698.80200 Day
719.10Indicators
RSI (14)
59.73MACD (12, 26)
14.05MACD Signal Line (9)
4.38MFI (14)
64.60ATR (14)
37.95ADX (14)
18.76ROC (21)
-6.47ROC (125)
18.00Pivot Analysis
Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 815.57 | 831.18 | 842.47 | 804.28 | 788.67 | 777.38 | 761.77 |
Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.
Volume Analysis
Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.
Remus Pharmaceuticals Ltd.
REMUS
Open Price | 809.90 |
Prev Close | 827.50 |
Upper Circuit | 959.90 |
Lower Circuit | 640.00 |
Volume | 3,200 |
Average Traded Price | 803.44 |
Historical Performance
| 1 Day | NA |
| 5 Days | NA |
| 1 Month | NA |
| 3 Months | NA |
| 1 Year | NA |
| 5 Years | NA |
| 10 Years | NA |